An Oral History of Neuropsychopharmacology The First Fifty Years Peer Interviews

List Price: $19.95

Add to Cart

An Oral History of Neuropsychopharmacology The First Fifty Years Peer Interviews
 

Volume 1: Starting Up

Series edited by Thomas A Ban M.D.
Volume editor Edward Shorter PhD

THE SERIES
The 10 volumes in this series record a fifty year history of neuropsychopharmacology related by 213 pioneer clinical, academic, industrial and basic scientists in videotaped interviews, conducted by 66 colleagues between 1994 and 2008. These volumes include a preface by the series editor placing its contents in an historical context and linking each volume to the next. Each volume is dedicated to a former President of the ACNP and edited by a distinguished historian or Fellow of the College who provides an introduction to its themes and a biography of each scientist's career. The series provides insights into a half century of discovery and innovation with its rewards and disappointments, progress and setbacks, including future expectations and hopes for the field as a whole and the ACNP as an organization.


IN THIS VOLUME
Volume I, "Starting Up" is dedicated to Heinz Lehmann, President, 1965 and edited by
Edward Shorter, a distinguished historian and professor of the history of medicine and
psychiatry. ¬The 22 pioneers, all men and predominantly Americans, include trialists,
pharmacologists and clinical scientists. From 1952 to the mid 1960s the earliest clinical
trials of the first psychotropic drugs took place in the V.A., private practice and State
hospitals. ¬Thousands of people with untreated mental illness benefited for the first
time. Psychoanalysis dominated academia, the pharmaceutical industry had barely
awakened to the potential for treatment of mental illness and clinical pharmacology
was an infant discipline. But the NIH and NIMH expanded dramatically, funded by
an enthusiastic Congress and the FDA was empowered to insist on drug efficacy as well
as safety. Basic scientists began to make the first linkages between serendipitous clinical
efficacy and putative neurochemical mechanisms of action.


Publication Date:
2011-11-29
ISBN/EAN13:
1461009642 / 9781461009641
Page Count:
406
Binding Type:
US Trade Paper
Trim Size:
6.69" x 9.61"
Language:
English
Color:
Black and White
Related Categories:
Medical / History




Site Help Order Help Policies Contact